| _version_ |
1860797891126231040
|
| building |
INTELEK Repository
|
| collection |
Online Access
|
| collectionurl |
https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072
|
| date |
2024-08-26 16:13:35
|
| eventvenue |
Equatorial Hotel, Penang
|
| format |
Restricted Document
|
| id |
14551
|
| institution |
UniSZA
|
| originalfilename |
2513-01-FH03-FSK-19-32217.pdf
|
| person |
Khairul
|
| recordtype |
oai_dc
|
| resourceurl |
https://intelek.unisza.edu.my/intelek/pages/view.php?ref=14551
|
| spelling |
14551 https://intelek.unisza.edu.my/intelek/pages/view.php?ref=14551 https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072 Restricted Document Conference Conference Paper application/pdf 3 1.7 Adobe Acrobat Pro DC 20.6.20042 Khairul 2024-08-26 16:13:35 2513-01-FH03-FSK-19-32217.pdf UniSZA Private Access Modulation of macrophage activation marker induced by recombinant Mycobacterium smegmatis expressing Antigen-85B Tuberculosis (TB) remains a major worldwide health problem which causes more than 1.3 million deaths annually. The development of a new vaccine as a replacement of Bacille Calmette Guerin (BCG) or to improve its efficacy is one of the goals mooted by the World Health Organization (WHO) to control TB. Mycobacterium smegmatis (M. smegmatis) is nonpathogenic and commensal in humans, which shares many characteristics with Mycobacterium tuberculosis (M. tuberculosis). Mycobacterial vectors including M. smegmatis have been successfully used in the development of experimental vaccines against TB International Conference on Molecular Diagnostics and Biomarker Discovery 2019 Equatorial Hotel, Penang
|
| spellingShingle |
Modulation of macrophage activation marker induced by recombinant Mycobacterium smegmatis expressing Antigen-85B
|
| summary |
Tuberculosis (TB) remains a major worldwide health problem which causes more than 1.3 million deaths annually. The development of a new vaccine as a replacement of Bacille Calmette Guerin (BCG) or to improve its efficacy is one of the goals mooted by the World Health Organization (WHO) to control TB. Mycobacterium smegmatis (M. smegmatis) is nonpathogenic and commensal in humans, which shares many characteristics with Mycobacterium tuberculosis (M. tuberculosis). Mycobacterial vectors including M. smegmatis have been successfully used in the development of experimental vaccines against TB
|
| title |
Modulation of macrophage activation marker induced by recombinant Mycobacterium smegmatis expressing Antigen-85B
|
| title_full |
Modulation of macrophage activation marker induced by recombinant Mycobacterium smegmatis expressing Antigen-85B
|
| title_fullStr |
Modulation of macrophage activation marker induced by recombinant Mycobacterium smegmatis expressing Antigen-85B
|
| title_full_unstemmed |
Modulation of macrophage activation marker induced by recombinant Mycobacterium smegmatis expressing Antigen-85B
|
| title_short |
Modulation of macrophage activation marker induced by recombinant Mycobacterium smegmatis expressing Antigen-85B
|
| title_sort |
modulation of macrophage activation marker induced by recombinant mycobacterium smegmatis expressing antigen-85b
|